Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
about
RNAi-Based Functional Genomics Identifies New Virulence Determinants in Mucormycosis.Drug development challenges and strategies to address emerging and resistant fungal pathogens.Combination therapy for the treatment of pulmonary mold infections.Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.In Vitro Combination of Isavuconazole with Echinocandins against Azole-Susceptible and -Resistant Aspergillus spp.
P2860
Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Monotherapy or combination the ...... treating murine mucormycosis.
@en
type
label
Monotherapy or combination the ...... treating murine mucormycosis.
@en
prefLabel
Monotherapy or combination the ...... treating murine mucormycosis.
@en
P2093
P2860
P356
P1476
Monotherapy or combination the ...... r treating murine mucormycosis
@en
P2093
Ashraf S Ibrahim
John E Edwards
Nkechi Azie
Priya Uppuluri
Teclegiorgis Gebremariam
P2860
P304
P356
10.1093/JAC/DKW433
P407
P577
2016-10-24T00:00:00Z